��������

Eric H. has over 18 years of work experience in the pharmaceutical industry. Eric is currently the Head of US Operations at Overland Pharmaceuticals since February 2023, where they are responsible for overseeing the company's operations in the United States. Prior to this role, they worked as the Vice President of Corporate Development and Strategy at Overland Pharmaceuticals since March 2021.

Before joining Overland Pharmaceuticals, Eric held the position of Senior Director, Business Development at Turning Point Therapeutics from 2020 to 2021. Eric also has extensive experience at Gilead Sciences, where they worked for 10 years from 2010 to 2020. During their time at Gilead Sciences, they held various roles including Research Scientist II, Senior Scientist I, and Senior Scientist II, focusing on research and business development diligence.

Additionally, Eric worked as a Research Scientist at Mitsubishi Tanabe Pharma America from 2006 to 2009 and as a Research Associate at The Scripps Research Institute from 2003 to 2006. Eric has a strong background in research and development within the pharmaceutical industry.

Eric H. obtained a Ph.D. in Organic Chemistry from UCLA between 1999 and 2003. Additionally, they pursued a Postgraduate Degree at Scripps Research, although the start and end years are not available.